Neighbors Elizabeth, Brunn Lia, Casamento-Moran Agostina, Martin Rebecca
International Center for Spinal Cord Injury, Hugo W. Moser Research Institute at Kennedy Krieger Institute, Baltimore, MD 21205, USA.
Department of Biomedical Engineering; Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
Children (Basel). 2024 Sep 12;11(9):1116. doi: 10.3390/children11091116.
Limited research exists for use of transcutaneous spinal stimulation (TSS) in pediatric spinal cord injuries (SCI) to improve walking outcomes, especially in children diagnosed with SCI secondary to acute flaccid myelitis (AFM).
This case series demonstrates the feasibility and efficacy of TSS paired with gait training in children diagnosed with AFM.
A total of 4 participants diagnosed with incomplete SCI secondary to AFM completed 22, 2-h therapy sessions over 5-8 weeks. TSS paired with body weight-supported treadmill training (BWSTT) was provided for the first 30 min of each session. Changes in walking function were assessed through the 6 min walk test (6MWT), Timed Up and Go (TUG), 10 m walk test (10MWT), and walking index for spinal cord injury II (WISCI-II). To assess safety and feasibility, pain, adverse events, and participant and therapist exertion were monitored.
All participants tolerated the TSS intervention without pain or an adverse response. Changes in the 6MWT exceeded the minimal clinically important difference (MCID) for three participants and WISCI-II exceeding the minimal detectable change (MDC) for two of the participants.
These results demonstrate that TSS is a safe and clinically feasible intervention for pediatric patients with AFM and may supplement gait-based interventions to facilitate improvements in walking function.
关于经皮脊髓刺激(TSS)用于小儿脊髓损伤(SCI)以改善步行结果的研究有限,尤其是在诊断为继发于急性弛缓性脊髓炎(AFM)的SCI儿童中。
本病例系列证明了TSS联合步态训练对诊断为AFM的儿童的可行性和有效性。
共有4名诊断为继发于AFM的不完全性SCI的参与者在5-8周内完成了22次,每次2小时的治疗课程。每次课程的前30分钟提供TSS联合体重支持跑步机训练(BWSTT)。通过6分钟步行测试(6MWT)、计时起立行走测试(TUG)、10米步行测试(10MWT)和脊髓损伤步行指数II(WISCI-II)评估步行功能的变化。为评估安全性和可行性,监测疼痛、不良事件以及参与者和治疗师的劳累程度。
所有参与者均耐受TSS干预,无疼痛或不良反应。三名参与者的6MWT变化超过最小临床重要差异(MCID),两名参与者的WISCI-II超过最小可检测变化(MDC)。
这些结果表明,TSS对患有AFM的儿科患者是一种安全且临床可行的干预措施,并且可能补充基于步态的干预措施以促进步行功能的改善。